Stoke Therapeutics, Inc. — Form 8-K
Filed September 25, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Stoke Therapeutics filed an 8-K on 2026-09-25 reporting Item 5.02 (officer compensation arrangements) with an event date of 2026-09-22. The filing header indicates departure/election of directors or officer appointment, but the actual text content is not provided in the document excerpt—only metadata, XBRL schema files, and filing structure are visible. No specific counterparties, dollar amounts, share counts, dates, or changes are disclosed in the available text.
Why this rating
Routine 8-K Item 5.02 filing; actual compensation details absent from excerpt. Standard disclosure requirement.
Extracted items
See more from September 25, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.